Brooks Laboratories Limited has announced the closure of its trading window for designated persons and their immediate relatives. This restriction will be effective from Thursday, January 1, 2026. The trading window will remain closed until 48 hours after the declaration of the Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31, 2025. The company will provide further details regarding the Board Meeting and the opening of the trading window in due course. This measure is in compliance with the Securities and Exchange Board of India (Prohibition of Insider Trading) regulations and the company's internal code of conduct for preventing insider trading.